| Net Cash Provided by (Used in) Operating Activities |
$404,880,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$448,525,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
58,179,313 |
shares |
834% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$43,645,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$216,723,000 |
USD |
1364% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$5,687,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
-100% |
Q3 2025 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$7,229,000 |
USD |
4955% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$2,823,000 |
USD |
28130% |
Q3 2025 |
Q3 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
$8,509,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Current Income Tax Expense (Benefit) |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$1,382,661,000 |
USD |
789% |
Q3 2025 |
Q3 2025 |
| Current State and Local Tax Expense (Benefit) |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$7,229,000 |
USD |
22491% |
Q3 2025 |
Q3 2025 |
| Deferred State and Local Income Tax Expense (Benefit) |
$827,000 |
USD |
|
Q3 2025 |
Q3 2025 |
| Interest Expense |
$7,866,000 |
USD |
938% |
Q3 2025 |
Q3 2025 |